Transplantation最新文献

筛选
英文 中文
Beyond Chronological Age: Biological Aging as the Next Frontier in Transplantation. 超越实足年龄:生物老化是移植的下一个前沿。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-09-16 DOI: 10.1097/TP.0000000000005899
Hao Zhou
{"title":"Beyond Chronological Age: Biological Aging as the Next Frontier in Transplantation.","authors":"Hao Zhou","doi":"10.1097/TP.0000000000005899","DOIUrl":"https://doi.org/10.1097/TP.0000000000005899","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Highlights. 研究突出了。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-09-16 DOI: 10.1097/TP.0000000000005907
Aleksandra Djordjevic, Natasha M Rogers
{"title":"Research Highlights.","authors":"Aleksandra Djordjevic, Natasha M Rogers","doi":"10.1097/TP.0000000000005907","DOIUrl":"https://doi.org/10.1097/TP.0000000000005907","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicaid Expansion and its Association With Liver Transplant Outcomes in Adults. 医疗补助扩大及其与成人肝移植结果的关系。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-09-14 DOI: 10.1097/TP.0000000000005896
Miguel Nunez, Holly P Shifman, Amy M Shui, Jennifer C Lai, Sharad Wadhwani
{"title":"Medicaid Expansion and its Association With Liver Transplant Outcomes in Adults.","authors":"Miguel Nunez, Holly P Shifman, Amy M Shui, Jennifer C Lai, Sharad Wadhwani","doi":"10.1097/TP.0000000000005896","DOIUrl":"https://doi.org/10.1097/TP.0000000000005896","url":null,"abstract":"<p><strong>Background: </strong>We previously found that Medicaid expansion improved outcomes in pediatric liver transplantation. In this study, we examined whether Medicaid expansion was associated with improved adult liver transplant outcomes over a 10-y period.</p><p><strong>Methods: </strong>Using the Scientific Registry of Transplant Recipients database, we analyzed adults who received liver transplants between January 1, 2010, and December 31, 2020. The primary outcomes were posttransplant graft survival and patient survival. Medicaid expansion status was treated as a time-varying covariate. Cox regression was used to evaluate the relationship between Medicaid expansion, insurance type, and other socioeconomic factors with all-cause graft failure.</p><p><strong>Results: </strong>65,856 adult transplant recipients were included. Seventy-one percent of recipients were in states that implemented Medicaid expansion during the study period. The median age at transplant was 58 y, 85% were White, and 34% were female. Fifty-three percent of patients had private insurance, 29% Medicare and 15% Medicaid. Medicaid expansion was associated with an 8% decreased risk of graft failure/death (HR 0.92; CI, 0.89-0.96; P < 0.001) after adjustment. This effect was greater in patients who had not yet qualified for Medicare, with a 10% decreased risk of graft failure/death (HR 0.90; CI, 0.86-0.93; P < 0.001). In a sensitivity analysis, comparing pre- and postexpansion outcomes over a 3-y period in states that expanded Medicaid, there was a 15% decrease in the risk of graft failure/death (HR, 0.85; CI, 0.80-0.91; P < 0.001).</p><p><strong>Conclusions: </strong>Medicaid expansion was associated with improved outcomes. This suggests that broader access to comprehensive and continuous health insurance may improve long-term outcomes following liver transplantation.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decarbonizing Lifesaving Care: The Case for Greener Economic Organ Transport. 脱碳救生护理:绿色经济器官运输的案例。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-09-11 DOI: 10.1097/TP.0000000000005912
Carlos F Gould, Hyoduk Shin, Gabriel T Schnickel
{"title":"Decarbonizing Lifesaving Care: The Case for Greener Economic Organ Transport.","authors":"Carlos F Gould, Hyoduk Shin, Gabriel T Schnickel","doi":"10.1097/TP.0000000000005912","DOIUrl":"https://doi.org/10.1097/TP.0000000000005912","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond Transplant Volume: Equity as the Next Measure of Transplant Progress in India. 超越移植量:公平是印度移植进展的下一个衡量标准。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-09-10 DOI: 10.1097/TP.0000000000005903
Khushboo Saxena, Manish R Balwani, Vivek B Kute
{"title":"Beyond Transplant Volume: Equity as the Next Measure of Transplant Progress in India.","authors":"Khushboo Saxena, Manish R Balwani, Vivek B Kute","doi":"10.1097/TP.0000000000005903","DOIUrl":"https://doi.org/10.1097/TP.0000000000005903","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148921083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
International Travel for Organ Transplantation: 2024 Multinational Survey of Routes, Organs, and Donor Types. 器官移植的国际旅行:2024年路线、器官和供体类型的跨国调查。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-09-10 DOI: 10.1097/TP.0000000000005893
Dominique E Martin, Yashan Jiang, Amy Lundgren, Georgina Soo, Riadh A S Fadhil, Benita Padilla, Jayme E Locke, Maggie Kam-Man Ma, Elmi Muller, Alicia Pérez-Blanco, Lola Perojo Vega, Georgina L Irish
{"title":"International Travel for Organ Transplantation: 2024 Multinational Survey of Routes, Organs, and Donor Types.","authors":"Dominique E Martin, Yashan Jiang, Amy Lundgren, Georgina Soo, Riadh A S Fadhil, Benita Padilla, Jayme E Locke, Maggie Kam-Man Ma, Elmi Muller, Alicia Pérez-Blanco, Lola Perojo Vega, Georgina L Irish","doi":"10.1097/TP.0000000000005893","DOIUrl":"https://doi.org/10.1097/TP.0000000000005893","url":null,"abstract":"<p><strong>Background: </strong>International travel for organ transplantation (ITOT) reportedly affects ≥2% of global solid organ transplant activity, yet detailed information about ITOT participants, organ types, travel configurations, and clinical settings remains scarce. Previous research has focused on living donor (LD) kidney transplantation for adults, often in the context of organ trafficking, leaving significant gaps in understanding of contemporary ITOT activities.</p><p><strong>Methods: </strong>A cross-sectional, international online survey was conducted between September 16 and December 15, 2024. Health professionals with experience caring for organ donors or transplant recipients were recruited via professional societies, social media, and personal networks. Participants reported on their most recent experiences of caring for incoming or outgoing transplant recipients and LDs involved in ITOT between January 1, 2023, and August 31, 2024. Data were analyzed using descriptive statistics.</p><p><strong>Results: </strong>Three hundred fifty-three respondents from 64 countries completed the survey; 166 (54%) of the 309 clinically active respondents had cared for ≥1 ITOT patient during the study period. Among 164 recipient cases, most involved adults (74%), kidney transplants (57%), and LD transplants (59%), with 40% occurring in private healthcare settings. Children comprised 23% of recipient cases. At least 164 unique travel routes were identified spanning 45 destination countries, with recipients originating from ≥69 countries and LDs from ≥54 countries.</p><p><strong>Conclusions: </strong>ITOT is a geographically diverse, global phenomenon. The substantive proportion of pediatric cases, deceased donor transplants, and private-sector procedures underscores the need for strengthened national and international data collection, governance frameworks, and equitable access policies to address the ethical and clinical challenges of ITOT.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148921138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two Genomes, one Outcome: Stratifying Donor and Recipient Polygenic Risk Score to Improve Kidney Allograft Longevity. 两个基因组,一个结果:分层供体和受体多基因风险评分改善同种异体肾移植寿命。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-09-10 DOI: 10.1097/TP.0000000000005908
Agnieszka Swiatecka-Urban, Nilay Mitash, Alexander F Koeppel, Stephen D Turner
{"title":"Two Genomes, one Outcome: Stratifying Donor and Recipient Polygenic Risk Score to Improve Kidney Allograft Longevity.","authors":"Agnieszka Swiatecka-Urban, Nilay Mitash, Alexander F Koeppel, Stephen D Turner","doi":"10.1097/TP.0000000000005908","DOIUrl":"https://doi.org/10.1097/TP.0000000000005908","url":null,"abstract":"<p><strong>Abstract: </strong>Kidney transplantation outcomes arise from complex interactions among donor organ quality, recipient susceptibility, and immunologic compatibility, yet conventional clinical risk models explain only a modest fraction of outcome variability. Polygenic risk scores (PRS) offer a promising framework to enhance transplant risk assessment by integrating genome-wide genetic information from both donor and recipient into biologically informed models. This narrative review examines the mechanistic basis for PRS application in kidney transplantation and variant clustering approaches that link polygenic signals to specific biological pathways underlying alloimmunity, fibrosis, and metabolic dysfunction. We compare current PRS construction methodologies, highlighting their respective strengths and limitations in transplant cohorts. Transplant PRS are distinguished from single-genome disease models by their capacity to capture dual-genome interactions, simultaneously quantifying inherited donor organ liability and recipient genetic susceptibility within an integrated framework. This dual-genome architecture requires novel risk stratification paradigms in which combined donor-recipient polygenic profiles inform pretransplant decision-making in ways that neither genome alone can achieve. However, current PRS contribute only incremental variance beyond established clinical predictors, and critical limitations persist, including European ancestry bias, small cohort sizes, incomplete replication, and undefined clinical actionability thresholds. We critically evaluate these implementation barriers and outline future directions for integrating dual-genome PRS with clinical, molecular, and environmental data. The longer-term goal is to advance precision kidney transplantation through applications such as donor selection, immunosuppression tailoring, and individualized posttransplant surveillance. Realizing this potential will require validation in adequately powered, ancestry diverse, prospective transplant cohorts.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the Antirejection Effects of the Dual ICOS and CD28 Antagonist Acazicolcept (ALPN-101) in Mouse Skin and Heart Transplantation Models. 双ICOS和CD28拮抗剂阿卡齐唑肽(ALPN-101)在小鼠皮肤和心脏移植模型中的抗排斥作用研究。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-09-10 DOI: 10.1097/TP.0000000000005897
Leigang Guo, Xiaojingnan Ma, Tingting Ma, Zhen Yang, Lin Li, Yaojuan Liu, Jianxi Wang, Panpan Zhan, Zhongyang Shen
{"title":"Study on the Antirejection Effects of the Dual ICOS and CD28 Antagonist Acazicolcept (ALPN-101) in Mouse Skin and Heart Transplantation Models.","authors":"Leigang Guo, Xiaojingnan Ma, Tingting Ma, Zhen Yang, Lin Li, Yaojuan Liu, Jianxi Wang, Panpan Zhan, Zhongyang Shen","doi":"10.1097/TP.0000000000005897","DOIUrl":"https://doi.org/10.1097/TP.0000000000005897","url":null,"abstract":"<p><strong>Background: </strong>T cell-mediated rejection significantly constrains the success of organ transplantation. T-cell activation relies on the complementary CD28 and ICOS costimulatory pathways. Thus, this research assessed a new dual CD28/ICOS antagonist, acazicolcept, in rigorous allogeneic transplantation models.</p><p><strong>Methods: </strong>Mouse models for allogeneic skin transplantation and abdominal heterotopic heart transplantation were developed. Recipients received acazicolcept, PBS, FK506, or single-pathway antagonists (belatacept or prezalumab). Graft viability, histopathological analysis, and T-cell infiltration were evaluated. Flow cytometry assessed spleen and blood lymphocyte subsets and costimulatory molecules. Donor-specific antibodies and graft C4d deposition were assessed to evaluate humoral responses.</p><p><strong>Results: </strong>Acazicolcept significantly extended the median survival time of skin and heart allografts to 31 d and 42.5 d, respectively, substantially surpassing other groups and mitigated histopathological damage. Mechanistic investigations demonstrated that the drug simultaneously downregulated the surface expression of CD28 and ICOS on T cells; effectively inhibited the development of effector memory T cells (Tem); and reduced the expression of PD-1 and CD69, reflecting a profound attenuation of early T-cell activation. Moreover, acazicolcept markedly inhibited humoral immune responses, as demonstrated by diminished C4d deposition in grafts and lowered levels of donor-specific antibody-IgG/IgM in peripheral blood.</p><p><strong>Conclusions: </strong>Acazicolcept exhibits robust, superior antirejection efficacy compared with single-pathway blockades by concurrently inhibiting CD28 and ICOS signals. This dual mechanism effectively suppresses T-cell activation, effector memory differentiation, and the subsequent antibody-mediated response, offering a robust preclinical justification for its clinical advancement in solid organ transplantation.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148921112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beating Heart Implantation-Added Pain, Little Gain? 跳动的心脏植入——多了痛苦,少了收获?
IF 4.9 2区 医学
Transplantation Pub Date : 2026-09-10 DOI: 10.1097/TP.0000000000005898
John M Trahanas, Swaroop Bommareddi, Aaron M Williams
{"title":"Beating Heart Implantation-Added Pain, Little Gain?","authors":"John M Trahanas, Swaroop Bommareddi, Aaron M Williams","doi":"10.1097/TP.0000000000005898","DOIUrl":"https://doi.org/10.1097/TP.0000000000005898","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148921061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Target Trial Emulation in Solid Organ Transplantation: Aligning Observational Studies With Randomized, Controlled Clinical Trial Principles. 实体器官移植的靶试验模拟:将观察性研究与随机对照临床试验原则相结合。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-09-10 DOI: 10.1097/TP.0000000000005906
Alvaro Assis de Souza, Dennis A Hesselink, David van Klaveren
{"title":"Target Trial Emulation in Solid Organ Transplantation: Aligning Observational Studies With Randomized, Controlled Clinical Trial Principles.","authors":"Alvaro Assis de Souza, Dennis A Hesselink, David van Klaveren","doi":"10.1097/TP.0000000000005906","DOIUrl":"https://doi.org/10.1097/TP.0000000000005906","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148930998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书